Saudi Arabia pharmaceutical market is expected to grow at a significant CAGR in the forecast period. The rise in the prevalence of lifestyle diseases owing to the adoption of a sedentary lifestyle thereby leaving less time for physical activities. The surge in consumption of junk food and high sugar-containing food items and beverages is affecting the health of consumers adversely. The development of healthcare infrastructure and the increase in efforts by the leading authorities for technological up-gradation of the existing system is fostering the growth of the pharmaceutical market. An increase in awareness among the consumers regarding the health insurance plans and reimbursement policies is aiding in increasing the demand for quality healthcare treatment services which in turn is fueling the pharmaceutical market growth in the next five years. An increase in the occurrence of non-communicable diseases requiring drug prescription for treatment is fueling the demand for the pharmaceutical market. The rise in disposable income among middle-class families is increasing the expenditure capacity of consumers to afford branded pharmaceutical drugs. The rise in initiatives taken by the government to promote foreign direct investment for the development of the pharmaceutical sector and privatization of the hospitals is influencing the pharmaceutical market growth.

Saudi Arabia pharmaceutical market is segmented into drug type, product type, application, distribution channel, regional distribution, and company. Based on application, the market can be divided into cardiovascular, musculoskeletal, oncology, anti-infective, metabolic disorder, and others. The cardiovascular segment is expected to account for a major market share in the forecast period, 2022-2026. Changes in lifestyle preferences and prevalence of circulatory disorders are the major driver for the growth of this segment. Also, the increase in the occurrence of sugar level disorder is fueling the occurrence of diabetes among the individuals which is a major reason responsible for the growth of cardiovascular disorders in the region.

The major players operating on the pharmaceutical market are Novartis Saudi Arabia, Pfizer Saudi Limited, Glenmark Pharmaceuticals Saudi Arabia, Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), Tabuk Pharmaceuticals Manufacturing Co., Jamjoom Pharmaceuticals Co, Julphar Pharmaceuticals, GlaxoSmithKline Saudi Arabia Limited, Baxter Company Limited (BCL), Saudi Arabia, AstraZeneca Saudi Arabia, and others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022–2026

Objective of the Study:

  • To analyze and estimate the market size of Saudi Arabia pharmaceutical market from 2016 to 2019.
  • To estimate and forecast the market size of Saudi Arabia pharmaceutical market from 2020 to 2026 and growth rate until 2026.
  • To classify and forecast Saudi Arabia pharmaceutical market based on drug type, product type, application, distribution channel, regional distribution, and company.
  • To identify dominant region or segment in the Saudi Arabia pharmaceutical market.
  • To identify drivers and challenges for Saudi Arabia pharmaceutical market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Saudi Arabia pharmaceutical market.
  • To identify and analyze the profile of leading players operating in Saudi Arabia pharmaceutical market.
  • To identify key sustainable strategies adopted by market players in Saudi Arabia pharmaceutical market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of Saudi Arabia Pharmaceutical market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research. 

Key Target Audience:

  • Pharmaceuticals manufacturing companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances related to pharmaceutical market

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, Saudi Arabia pharmaceutical market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Saudi Arabia Pharmaceutical Market, By Drug Type:
    • Generic Drugs
    • Branded Drugs
  • Saudi Arabia Pharmaceutical Market, By Product Type:
    • Prescription Drugs
    • Over-The-Counter Drugs
  • Saudi Arabia Pharmaceutical Market, By Application:
    • Cardiovascular
    • Musculoskeletal
    • Oncology
    • Anti-infective
    • Metabolic Disorder
    • Others
  • Saudi Arabia Pharmaceutical Market, By End User:
    • Retail Pharmacy
    • Hospital Pharmacy
    • E-Pharmacy
  • Saudi Arabia Pharmaceutical Market, By Region:
    • Western Region
    • Northern & Central Region
    • Eastern Region
    • Southern Region

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Saudi Arabia pharmaceutical market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Saudi Arabia pharmaceutical market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

1.     Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Saudi Arabia Pharmaceutical Market

4.    Executive Summary

5.    Voice of Customers

6.    Saudi Arabia Pharmaceutical Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Drug Type (Generic Drugs v/s Branded Drugs)

6.2.2.     By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

6.2.3.     By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

6.2.4.     By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

6.2.5.     By Region

6.2.6.     By Company (2020)

6.3.  Product Market Map

7.    Saudi Arabia Generic Drugs Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product Type

7.2.2.     By Application

7.2.3.     By Distribution Channel

8.    Saudi Arabia Branded Drugs Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product Type

8.2.2.     By Application

8.2.3.     By Distribution Channel

9.    Market Dynamics

9.1.     Drivers

9.2.     Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  Saudi Arabia Economic Profile

13.  Competitive Landscape

13.1.    Competition Outlook

13.2.    Company Profiles

13.2.1.  Novartis Saudi Arabia

13.2.2.  Pfizer Saudi Limited

13.2.3.  Glenmark Pharmaceuticals Saudi Arabia

13.2.4.  Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)

13.2.5.  Tabuk Pharmaceuticals Manufacturing Co.

13.2.6.  Jamjoom Pharmaceuticals Co

13.2.7.  Julphar Pharmaceuticals

13.2.8.  GlaxoSmithKline Saudi Arabia Limited

13.2.9.  Baxter Company Limited (BCL), Saudi Arabia

13.2.10.                AstraZeneca Saudi Arabia

14.  Strategic Recommendations

15.  About Us & Disclaimer